YOLFTbeta
Changzhou Qianhong Biopharma Co Ltd

Changzhou Qianhong Biopharma Co Ltd

002550 · SHE · Healthcare / Drug Manufacturers - Specialty & Generic

6.15CNY-0.21 (-3.30%)

Price History

Full chart

Market Stats

Previous Close6.36
Open6.35
Day Range6.12 – 6.36
52-Week Range5.58 – 9.26
Volume13.61M
Market Cap8.43B
P/E (TTM)28.65
Forward P/E13.77
EPS0.23
Dividend Yield2.37%
Beta0.02
50-Day Avg6.70
200-Day Avg7.15

About

Changzhou Qianhong Biopharma CO.,LTD manufactures and distributes polysaccharide and protease drugs in China. The company offers heparin sodium, heparin calcium, enoxaparin sodium, dalteparin sodium, nadroparin calcium, pancreatin, heparinoid API, kallidinogenase, and asparaginase, as well as offers berry source and target diet box. It also provides low molecular weight heparin, compound digestive enzyme preparations, and health products. In addition, the company exports its products. The company was founded in 1971 and is headquartered in Changzhou, China.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEOMr. Ke Wang
  • Employees1.04K
  • HeadquartersLife and Health Industrial Park, Changzhou, China, 213125, China
  • Websitehttps://www.qhsh.com.cn

Leadership

  • Mr. Ke WangGM & Non-Independent Director · b. 1983
  • Mr. Yi YaoCFO & Board Secretary · b. 1982
  • Mr. Xiang ZhouDeputy GM & Non-Independent Director · b. 1982
  • Mr. Chizhou JiangNon-Independent Director & Deputy GM · b. 1990
  • Mr. Tao HaiDeputy General Manager · b. 1969
  • Ms. Aiqun XiaoAudit Director · b. 1972
  • Mr. Lijun WeiDirector · b. 1972
  • Ms. Jie HuangDirector · b. 1987
  • Mr. Guming WangDirector & GM of Production Center · b. 1985

Financials

Income Statement

Currency: CNY2007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue283.53M469.07M743.80M1.14B731.26M728.59M860.78M814.61M757.05M776.39M1.07B1.32B1.68B1.67B1.87B2.30B1.81B1.53B1.57B
Growth (%)-+65.44%+58.57%+53.91%-36.12%-0.37%+18.14%-5.36%-7.07%+2.55%+37.23%+24.05%+26.74%-0.45%+12.43%+22.86%-21.24%-15.88%+2.95%
Cost of Revenue176.61M281.86M482.94M836.58M439.96M414.64M496.78M336.56M249.74M276.25M518.57M679.23M877.01M880.42M1.05B1.42B1.05B696.31M654.35M
Gross Profit108.98M189.78M260.85M308.19M297.69M313.95M364.00M478.05M507.31M500.14M546.90M642.45M798.14M787.19M829.44M884.31M768.81M829.94M916.93M
Gross Margin38.44%40.46%35.07%26.92%40.71%43.09%42.29%58.68%67.01%64.42%51.33%48.61%47.65%47.20%44.24%38.39%42.38%54.38%58.36%
Operating Expense62.39M82.62M103.53M129.78M152.66M183.28M154.51M209.17M208.73M239.61M333.86M390.42M497.90M951.95M620.10M524.30M564.45M433.55M584.42M
Operating Income46.59M107.16M157.32M178.41M145.03M130.67M209.50M268.88M298.58M260.52M213.04M252.03M300.24M-164.76M209.34M360.01M204.36M396.39M332.51M
Operating Margin16.43%22.85%21.15%15.58%19.83%17.93%24.34%33.01%39.44%33.56%20.00%19.07%17.92%-9.88%11.17%15.63%11.26%25.97%21.16%
EBITDA58.39M123.34M166.29M186.18M191.71M147.88M165.84M206.18M218.27M184.64M182.58M183.39M303.46M280.26M221.82M287.33M231.41M346.73M516.54M
EBITDA Margin20.59%26.29%22.36%16.26%26.22%20.30%19.27%25.31%28.83%23.78%17.14%13.88%18.12%16.81%11.83%12.47%12.75%22.72%32.87%
Net Income45.63M90.44M125.69M150.53M152.25M161.80M187.02M245.04M267.15M224.46M183.00M221.35M262.56M-132.02M181.08M323.41M181.86M356.03M398.80M
Net Income Margin16.09%19.28%16.90%13.15%20.82%22.21%21.73%30.08%35.29%28.91%17.18%16.75%15.67%-7.92%9.66%14.04%10.02%23.33%25.38%
R&D8.89M14.26M22.60M-24.82M33.12M41.68M53.32M41.27M44.39M63.51M67.29M65.38M69.14M71.18M88.31M97.08M104.45M110.66M
R&D as % of Total Revenue3.14%3.04%3.04%-3.39%4.55%4.84%6.55%5.45%5.72%5.96%5.09%3.90%4.15%3.80%3.83%5.35%6.84%7.04%
Interest Expense7.19M7.68M6.48M10.49M3.98M1.93M623.05K970.36K9.30M16.76M16.73M19.42M19.53M9.10M1.78M5.46M6.17M1.50M459.11K
Interest Expense % of Total Revenue2.54%1.64%0.87%0.92%0.54%0.27%0.07%0.12%1.23%2.16%1.57%1.47%1.17%0.55%0.09%0.24%0.34%0.10%0.03%

Balance Sheet

Currency: CNY2007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets288.56M391.74M533.87M548.53M1.85B1.93B2.07B2.31B2.83B3.03B3.04B3.18B2.93B2.45B2.51B2.81B2.77B2.83B3.09B
Total Liabilities76.95M173.75M290.19M134.75M87.07M58.54M95.77M178.06M538.67M609.33M591.41M640.11M601.65M386.35M390.24M372.53M292.17M313.87M320.64M
Total Equity211.52M217.95M243.65M394.15M1.72B1.83B1.93B2.10B2.27B2.40B2.44B2.53B2.33B2.08B2.13B2.45B2.45B2.52B2.77B
Cash83.94M115.62M99.92M123.31M1.36B1.22B561.62M145.30M166.35M146.24M186.34M419.53M202.99M516.11M617.81M409.26M576.23M439.95M491.05M
Total Debt61.15M83.00M116.00M84.00M29.00M-5.00M28.00M307.00M373.00M384.32M432.36M344.24M41.85M89.46M100.10M55.62M20.02M-
Net Debt-22.79M-32.62M16.08M-39.31M-1.34B-1.22B-556.62M-117.30M140.65M226.76M197.98M12.83M141.25M-474.26M-528.34M-309.16M-520.12M-419.92M-

Cash Flow

Currency: CNY2007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow35.99M54.36M8.35M171.51M146.82M199.82M160.47M252.01M286.50M221.01M88.52M25.45M161.55M317.28M103.56M-71.47M533.33M514.71M361.36M
Investing Cash Flow-5.19M-7.39M-13.29M-10.65M-22.16M-260.48M-737.32M-611.67M-449.47M-201.41M90.44M290.76M185.03M459.53M95.28M-189.98M-175.10M-323.23M-
Financing Cash Flow27.27M-13.98M-10.39M-135.90M1.12B-86.63M-75.21M-57.56M178.95M-44.83M-133.31M-100.98M-567.77M-444.47M-104.17M11.02M-190.87M-324.71M-
Capital Expenditure6.97M7.41M13.37M10.64M26.31M64.20M127.59M90.53M215.78M138.94M87.63M103.53M100.68M62.53M90.37M70.99M100.33M90.64M141.60M
Free Cash Flow29.02M46.95M-5.02M160.88M120.51M135.62M32.88M161.49M70.73M82.08M892.39K-78.08M60.87M254.74M13.19M-142.46M433.00M424.07M219.76M
Dividends Paid6.73M35.83M43.39M123.50M42.41M57.63M80.21M80.56M104.05M110.83M118.35M123.83M152.88M303.97M149.98M149.98M152.98M151.52M150.43M
FCF to OCF80.64%86.38%-60.09%93.80%82.08%67.87%20.49%64.08%24.69%37.14%1.01%-306.87%37.68%80.29%12.73%199.32%81.19%82.39%60.81%
Dividend Paid to FCF23.20%76.31%-864.75%76.77%35.19%42.50%243.96%49.88%147.11%135.03%13261.95%-158.58%251.15%119.32%1137.42%-105.27%35.33%35.73%68.45%

Earnings

Report DateMar 31, 2011Jun 30, 2011Sep 30, 2011Dec 31, 2011Mar 31, 2012Jun 30, 2012Nov 28, 2012Feb 27, 2013May 29, 2013Aug 28, 2013Nov 27, 2013Feb 26, 2014May 28, 2014Aug 23, 2014Oct 24, 2014Jan 31, 2015Apr 24, 2015Aug 21, 2015Oct 23, 2015Feb 26, 2016Apr 25, 2016Aug 17, 2016Oct 21, 2016Feb 7, 2017Apr 24, 2017Aug 21, 2017Oct 23, 2017Feb 27, 2018Apr 19, 2018Aug 22, 2018Oct 24, 2018Apr 22, 2019Aug 23, 2019Oct 24, 2019Apr 25, 2020Aug 21, 2020Oct 30, 2020Apr 9, 2021Aug 21, 2021Nov 1, 2021Apr 25, 2022Aug 9, 2022Oct 27, 2022Apr 15, 2023Jul 21, 2023Oct 24, 2023Apr 25, 2024Aug 16, 2024Oct 17, 2024Apr 18, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate-------------0.040.040.05-0.080.060.09----0.090.090.09----------------------------
EPS Actual0.030.030.030.030.020.040.030.040.030.040.040.040.040.050.060.050.050.060.050.060.050.060.030.030.060.060.060.010.070.060.040.010.070.04-0.020.070.070.040.030.08-0.010.060.050.040.030.06-0.010.060.100.130.080.100.010.070.05
Surprise-------------25.00%50.00%0.00%--25.00%-16.67%-33.33%-----33.33%-33.33%-33.33%----------------------------
Timing--------------Pre-marketAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursPre-marketAfter-hoursPre-marketAfter-hoursPre-marketPre-marketAfter-hoursPre-marketAfter-hoursPre-marketAfter-hoursPre-marketPre-marketAfter-hours-Pre-marketAfter-hoursPre-market--Pre-market---Pre-marketPre-marketPre-market-Pre-marketPre-market-----

Key Statistics & Ratios

Market Cap8.43B
Enterprise Value7.25B
Trailing P/E28.65
Forward P/E13.77
PEG Ratio0.00
Price / Sales5.75
Price / Book3.05
EPS0.23
Book Value2.17
Revenue (TTM)1.47B
Gross Profit (TTM)824.53M
EBITDA327.63M
Profit Margin20.00%
Operating Margin14.66%
Return on Equity9.98%
Return on Assets5.41%
Shares Outstanding1.28B
Shares Float707.37M
Beta0.02
Dividend Yield2.37%
Dividend Rate0.15
Payout Ratio63.08%

Dividends

20261×
0.15May 29, 2026
20251×
0.12May 29, 2025
20241×
0.12May 29, 2024
20231×
0.12May 26, 2023
20221×
0.12May 25, 2022
20211×
0.12May 21, 2021
20201×
0.25May 27, 2020
20191×
0.12May 28, 2019
20181×
0.08Jun 21, 2018
20171×
0.08Jun 1, 2017
20161×
0.15May 31, 2016
20151×
0.15May 26, 2015
20141×
0.13Apr 18, 2014
20131×
0.06May 17, 2013
20121×
0.04May 30, 2012
20111×
0.03May 25, 2011

Stock Splits

  • May 31, 20162:1
  • May 26, 20152:1
  • Apr 18, 20142:1